8-K: Roman DBDR Receives Nasdaq Deficiency for 10-Q Delay

Roman DBDR Acquisition Corp. II received a Nasdaq deficiency notice for failing to file its quarterly report, risking potential delisting.

Summary

• Received a deficiency letter from The Nasdaq Stock Market LLC on August 28, 2025.
• Not in compliance with Nasdaq Listing Rule 5250(c)(1) due to the failure to file its Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2025.
• The deficiency notice has no immediate effect on the listing of the company's securities on The Nasdaq Global Market.
• Has 60 calendar days, until October 27, 2025, to submit a plan to Nasdaq to regain compliance.
• If a plan is accepted, Nasdaq can grant an exception of up to 180 calendar days from the Quarterly Report's due date, or until February 16, 2026, to regain compliance.
• Intends to file the Quarterly Report as soon as practicable and, if necessary, submit a plan to Nasdaq to regain compliance.

Sentiment

Score: 3

Explanation: The filing indicates a significant compliance issue (failure to file a required financial report) which is a negative. While there's no immediate delisting and the company has a plan, the underlying failure is a serious concern for investors regarding operational efficiency and governance.

Positives

• The deficiency notice has no immediate effect on the listing of the company's securities on The Nasdaq Global Market.
• The company has a defined period and process to regain compliance, including submitting a plan and the opportunity to appeal a negative decision.

Negatives

• Failure to file the Quarterly Report on Form 10-Q for the period ended June 30, 2025, resulting in non-compliance with Nasdaq Listing Rule 5250(c)(1).
• Risk of potential delisting from The Nasdaq Global Market if compliance is not regained within the specified timelines.

Risks

• Potential delisting of the company's securities from The Nasdaq Global Market if it fails to regain compliance with Nasdaq Listing Rule 5250(c)(1).
• Failure to file the Quarterly Report on Form 10-Q as soon as practicable could escalate the compliance issue.
• Nasdaq may not accept the company's compliance plan, which would necessitate an appeal to a Nasdaq Hearings Panel.

Future Outlook

The company intends to file its Quarterly Report on Form 10-Q as soon as practicable and, if necessary, submit a plan to Nasdaq to regain compliance with listing requirements.

Management Comments

• We intend to file the Quarterly Report as soon as practicable and, if necessary, to submit a plan with Nasdaq to regain compliance.

Industry Context

Roman DBDR Acquisition Corp. II is a Special Purpose Acquisition Company (SPAC) formed to pursue a business combination, primarily in cybersecurity, artificial intelligence, or financial technology. Compliance with listing rules, including timely financial reporting, is crucial for SPACs to maintain investor confidence and facilitate future merger activities. A deficiency notice for a delayed 10-Q is a common compliance issue that can affect investor perception and the company's ability to execute its strategic objectives.

Stakeholder Impact

• Shareholders face increased uncertainty and potential risk of delisting if the company fails to regain compliance, which could negatively impact share value.
• Investors may view the company's operational and financial reporting controls negatively due to the delayed filing.

Next Steps

• File the Quarterly Report on Form 10-Q for the period ended June 30, 2025, as soon as practicable.
• Submit a plan to Nasdaq to regain compliance by October 27, 2025.
• Potentially appeal to a Nasdaq Hearings Panel if the compliance plan is not accepted.

Key Dates

Recommendation

While the company has received a deficiency notice for failing to file its 10-Q, which is a serious compliance issue, there is no immediate delisting threat, and management has stated its intent to rectify the situation promptly. Investors should hold to see if the company successfully files the report and regains compliance within the given timelines. A 'sell' recommendation would be premature without further developments, but the situation warrants close monitoring due to the inherent risks of non-compliance.

Keywords

Roman DBDR Acquisition Corp. II, DRDB, Nasdaq, Deficiency Notice, Form 10-Q, SEC Filing, Compliance, Delisting Risk, SPAC, Blank Check Company, Financial Reporting